PRODUCT FAMILY

ZEISS CT LUCIA Family

Treating a wide range of patients with a unique ZEISS Optic.

The CT LUCIA 621P/PY® – a new generation of aspheric IOL, applied on a monofocal hydrophobic C-loop platform. The patented asphericity concept of the ZEISS CT LUCIA is designed to mitigate against potential decentration issues and to confidently deliver good visual outcomes.

The architecture of the IOL enables very stable positioning in the capsular bag for consistent and excellent performance. The latest CT LUCIA 621P/PY comes in a new and improved fully preloaded injector system for an easy and intuitive cataract workflow.

  • Consistent visual outcomes¹
  • Excellent stability
  • Intuitive injector handling
  • ZEISS CT LUCIA 621P

    Aspheric C-loop

    • Monofocal
    • Aspheric (aberration-correcting)
    • Hydrophobic acrylic with heparin-coated2 surface
  • ZEISS CT LUCIA 621PY

    Aspheric C-loop

    • Monofocal
    • Aspheric (aberration-correcting)
    • Hydrophobic acrylic with heparin-coated2 surface
    • Blue light filter
  • ZEISS CT LUCIA 221P

    Spherical C-loop

    • Monofocal
    • Spheric
    • Hydrophobic acrylic with heparin-coated2 surface
Fig. 1. Influence of decentration on predicted mesopic visual acuity.

Consistent visual outcomes1

The sophisticated and patented ZEISS Optic (ZO) Asphericity Concept of the ZEISS CT LUCIA 621P/PY is designed to compensate for a wide range of aberrations resulting from different corneal shapes and lens positions. With its uniquely forgiving design it delivers good visual outcomes for a broad range of patients and surgical situations.

Consistent visual outcomes

Forgiving to decentration1

Every eye is as individual as the patient themselves. Typically, the human eye is not optically symmetric, which can lead to IOL decentration. Generally, IOL decentration can occur due to poor capsular or zonular support, decentered capsulorhexis, asymmetric shrinkage of the capsular bag, misplacement of the haptics or IOL luxation in eyes with pseudoexfoliation.

CT LUCIA 621P/PY IOLs, with ZEISS optic features, are designed to compensate for potential decentration and lens misalignments. Reducing the risk of decentration allows you more time to focus on your patients and their needs.

  • 1

    The data is taken from a simulation. The transferability of the results of such a simulation to patients with an actual implanted intraocular lenses has not yet been scientifically proven. Whether the simulated impressions correspond to the actual visual impressions must be clarified in future invasive studies.   

Excellent stability

ZEISS CT LUCIA 621P/PY IOLs feature an optic-haptic junction designed for refractive stability. Coupled with step-vaulted C-loop haptics, this enables centering while maximizing direct capsular contact, thus ensuring stability and supporting a consistent, stable axial IOL position in the capsular bag.

Excellent stability

Fig. 1: The behavior of the axial IOL position stability of the ZEISS CT LUCIA 621P over a duration of 1 week and 1 month.

The anterior chamber stability of the CT LUCIA 621P assessed over a period of 1 week and 1 month

The assessment was done by biometry measurement using the IOLMaster 700. Anterior chamber depth (ACD) was measured to reflect the position stability of the implanted IOL at the two post-operative visits (1 week (W1) and 1 month (M1)).1

Conclusion: The IOL performed stable over the duration of time with no significant shift in IOL position in the capsular bag.

  • 1

    Internal report on CT LUCIA 621P data collection (Dr Cuttita) - Version 1.1 dated 19.11.2019.   

Intuitive injector handling

The design of the latest fully preloaded injection system of the ZEISS CT LUCIA has been improved to make handling easier and intuitive for the target users. Recent enhancements simplify the surgical workflow, providing a smooth preparation process that enables successful implantation of the lens in an easy and efficient manner.

Intuitive injector handling

Intermediate position

An audible click to re-ensure that you have reached the right position before proceeding with the IOL implantation.

2 easy steps

Apply OVD and close the cartridge; the IOL is ready to be implanted. Just two steps for easy and intuitive injector preparation.

Step 1

Step 2

Injector usability testing

Positive feedback related to ease of use of the improved injector as well as a high level of reproducibility were shared by doctors and nurses during recent usability testing.1

Conclusion:

98 % of the testing surgeons and nurses agreed that the overall performance of the CT LUCIA 621P/PY is preferred over injections of choice, even over known gold standard injectors. Particularly advantageous was the homogenous injector force, resulting in a high percentage of reproducibility and ease to implant the lens in the bag.2

  • 1

    CT LUCIA 621P - Surgeon evaluation report (Apr-Sep 2019) - Report on surgery Performance CT LUCIA 621P injector.

  • 2

    Results are based on 521 implantations.   

Are you a patient?

Please visit our patient website for more information on cataract treatment:

Powerful as individual solution – Unstoppable together

The new ZEISS Cataract Workflow

By connecting devices, data and applications, the ZEISS portfolio enables a seamless integration from office to OR and back.

Downloads

    • CT LUCIA 201P Datasheet EN

      Pages: 2
      File size: 91 KB
    • CT LUCIA 211P Datasheet EN

      Pages: 2
      File size: 98 KB
    • CT LUCIA 221P Datasheet EN

      Pages: 2
      File size: 104 KB
    • CT LUCIA 611P / 611PY Datasheet EN

      Pages: 2
      File size: 106 KB
    • CT LUCIA 621P/PY Datasheet EN

      Pages: 2
      File size: 115 KB
    • CT LUCIA 601P/PY Datasheet EN

      Pages: 2
      File size: 120 KB
    • CT LUCIA 211P & 611P/PY Handling Instructions EN

      Pages: 2
      File size: 244 KB
    • CT LUCIA 221P & 621P/PY Handling Instructions EN

      Pages: 2
      File size: 149 KB

Handling instructions video

CT LUCIA 211P/611P/611PY

Handling instructions video

CT LUCIA 221P/621P/621P

Handling instructions video

Specification comparison

ZEISS CT LUCIA family

  • CT LUCIA 211P
    CT LUCIA 221P
    Optic Design
    Monofocal, spheric
    Monofocal, spheric
    Material

    Hydrophobic acrylic with heparin-coated2 surface   

    Hydrophobic acrylic with heparin-coated2 surface

    Optic Diameter
    6.0 mm
    6.0 mm
    Total Diameter
    13.0 mm
    13.0 mm
    Haptic
    Step vaulted
    Step vaulted
    Lens Design
    Single-piece
    Single-piece
    Incision Size
    2.2 – 2.6 mm (depending on diopter)

    2.2 – 2.6 mm (depending on diopter)

    Company Labeled A-Constant8
    119.8
    119.8
    Diopter Range
    From +4.0 to +34.0 D, 0.5 D increments

    From 0.0 to +34.0 D, 0.5 D increments

    Abbe Number
    51
    51
    ACD8
    6.03
    6.03
    Refractive Index
    1.49
    1.49
    Implantation in
    Capsular bag
    Capsular bag
    Injector / Cartridge Set

    BLUEJECT™ 2.0 Injector for diopter range +4.0 to +24.0 D

    BLUESERT™ 2.2 Injector for diopter range 0.0 to +24.0

    BLUEJECT 2.2 Injector for diopter range +24.5 to +30.0 D

    BLUESERT 2.4 Injector for diopter range +24.5 to +30.0

    BLUEJECT 2.4 Injector for diopter range +30.5 to +34.0 D

    BLUESERT 2.6 Injector for diopter range +30.5 to +34.0

  • CT LUCIA 611P
    CT LUCIA 611PY
    Optic Design
    Monofocal, aspheric (aberration correcting)
    Monofocal, aspheric (aberration correcting)
    Material

    Hydrophobic acrylic with heparin-coated2 surface

    Hydrophobic acrylic with heparin-coated2 surface and blue light filter

    Optic Diameter
    6.0 mm
    6.0 mm
    Total Diameter
    13.0 mm
    13.0 mm
    Haptic
    Step vaulted
    Step vaulted
    Lens Design
    Single-piece
    Single-piece
    Incision Size
    2.2 – 2.6 mm (depending on diopter)
    2.2 – 2.6 mm (depending on diopter)

    Company Labeled A-Constant8

    119.9
    119.9
    Diopter Range
    From +4.0 to +34.0 D, 0.5 D increments
    From +4.0 to +34.0 D, 0.5 D increments
    Abbe Number
    51
    50

    ACD8

    6.14
    6.14
    Refractive index
    1.49
    1.49
    Implantation in
    Capsular bag
    Capsular bag
    Injector / Cartridge Set

    BLUEJECT™ 2.0 Injector for diopter range +4.0 to +24.0 D

    BLUEJECT 2.0 Injectorfor diopter range +4.0 to +24.0 D

    BLUEJECT 2.2 Injector for diopter range +24.5 to +30.0 D

    BLUEJECT 2.2 Injectorfor diopter range +24.5 to +30.0 D

    BLUEJECT 2.4 Injector for diopter range +30.5 to +34.0 D

    BLUEJECT 2.4 Injectorfor diopter range +30.5 to +34.0 D
  • CT LUCIA 621P
    CT LUCIA 621PY
    Optic Design
    Monofocal, aspheric (aberration-correcting)
    Monofocal, aspheric (aberration-correcting)
    Material

    Hydrophobic acrylic with heparin-coated2 surface

    Hydrophobic acrylic with heparin-coated2 surface and blue light filter

    Optic Diameter
    6.0 mm
    6.0 mm
    Total Diameter
    13.0 mm
    13.0 mm
    Haptic
    Step vaulted
    Step vaulted
    Lens Design
    Single-piece
    Single-piece
    Incision Size
    2.2 – 2.6 mm (depending on diopter)
    2.2 – 2.6 mm (depending on diopter)

    Company Labeled A-Constant8

    120.2
    120.2
    Diopter Range
    From +0.0 to +34.0 D, 0.5 D increments
    From +0.0 to +34.0 D, 0.5 D increments
    Abbe Number
    51
    50

    ACD8

    6.29
    6.29
    Refractive index
    1.49
    1.49
    Implantation in
    Capsular bag
    Capsular bag
    Injector / Cartridge Set
    BLUESERT™ 2.2 Injector for diopter range +0.0 to +24.0
    BLUESERT 2.2 Injector for diopter range +0.0 to +24.0
    BLUESERT 2.4 Injector for diopter range +24.5 to +30.0
    BLUESERT 2.4 Injector for diopter range +24.5 to +30.0
    BLUESERT 2.6 Injector for diopter range +30.5 to +34.0
    BLUESERT 2.6 Injector for diopter range +30.5 to +34.0

Get more information now!

Your ZEISS representative will be in contact with you.

Form is loading...

/ 4
Next Step:
  • Step 1
  • Step 2
  • Step 3
Step 1
Step 2
Step 3

If you want to have more information on data processing at ZEISS please refer to our data privacy notice.

  • 1

    The data is taken from a simulation. The transferability of the results of such a simulation to patients with an actual implanted intraocular lenses has not yet been scientifically proven. Whether the simulated impressions correspond to the actual visual impressions must be clarified in future invasive studies.

  • 2

    Fragment of heparin used in IOL surface coating with no pharmacological, immunological or metabolic action.

  • 3

    Based on physiologically weighted MTF-area (subject to clinical verification)

  • 4

    For spherical aberration (SA) only

  • 5

    Internal report on CT LUCIA 621P data collection (Dr Cuttita) - Version 1.1 dated 19.11.2019.

  • 6

    CT LUCIA 621P - Surgeon evaluation report (Apr-Sep 2019) - Report on surgery Performance CT LUCIA 621P injector.

  • 7

    Results are based on 521 implantations.

  • 8

    For optimized A Constants and ACD Constants refer to IOLCon: www.iolcon.org